INC Research, a fast-growing life science contract research organization, is the winner of the prestigious Scrip Award as the top CRO for 2015.
INC (Nasdaq: INCR) executives received the award from the international Scrip organization in London on Wednesday. The Scrip Awards, now in their 11th year, are among the highest regarded in the life science and pharmaceutical industries. Industry executives determine the winners.
Quintiles, the world’s largest CRO which is based in Durham, and Wilmington-based PPD were finalists. Quintiles won the honor in 2014.
Earlier this year, INC also received the “Top CRO to Work With” in the CenterWatch Global Investigative Site Relationship Survey.
“INC Research employees are passionate about bringing new medicines to market to improve world health,” said Jamie Macdonald, Chief Executive Officer of INC.
“Being named ‘Best CRO’ is a true testament to their hard work and dedication, and our ability to collaborate effectively with customers and sites worldwide in the development of ground-breaking new therapies that improve patient lives. To be selected from among such a distinguished group of peers is an incredible honor. INC’s focus will continue to be first and foremost on meeting our customers’ needs for innovative and forward-thinking clinical development solutions that achieve their vision and ultimately benefit patients.”
Why was INC selected?
“Our judges selected INC Research based on its impressive growth as one of the world’s leading CROs and its ability not only to keep up with the changing needs of the environment but its effort to be an agent in driving positive change in the clinical development process,” said Mike Ward, Global Director of Content for Informa Pharma and Healthcare.
“The qualifying year was a milestone year for the Company, culminating in its initial public offering and its contribution to the development of a number of ground-breaking therapies. INC’s therapeutic focus, unique Trusted Process® clinical development methodology and significant commitment and progress in the development of strong site relationships really make it stand above our other nominations this year.”
For more about the awards, see:
